Published: 2018-12-08

Articles

COST- EFFECTIVENESS OF INTENSIVE LIPID LOWERING THERAPY WITH 80 MG OF ATORVASTATIN, VERSUS 10 MG OF ATORVASTATIN, FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN CANADA

Monika Wagner, Mireille Goetghebeur, Elizabeth Merikle, Ankur Pandya, Paula Chu, Douglas CA Taylor
Abstract 258 | PDF Downloads 156
PDF

ACCESS AND INTENSITY OF USE OF PRESCRIPTION ANALGESICS AMONG OLDER MANITOBANS

Cheryl A Sadowski, Anita G Carrie, Ruby E Grymonpre, Colleen J Metge, Philip St.John
Abstract 193 | PDF Downloads 97
PDF

Innovations in Pharmacology - CSPT 2009 Conference Abstracts

Saskatoon, Saskatchewan
Abstract 142 | PDF Downloads 116
PDF

VALIDITY OF PERINATAL PHARMACOEPIDEMIOLOGIC STUDIES USING DATA FROM THE RAMQ ADMINISTRATIVE DATABASE

Anick Bérard, Anaïs Lacasse
Abstract 307 | PDF Downloads 186
PDF

CLINICAL EVALUATION OF DE MARCO FORMULA AS AN ADJUNCTIVE THERAPY FOR INFECTED ISCHEMIC DIABETIC FOOT: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL

Héctor Álvarez Duarte, José I Fernández Montequín, Martha M Fors López, José Hernández Carretero, Miriam Mahia Vilas, Milagros García Mesa
Abstract 165 | PDF Downloads 86
PDF

THE UNINTENDED (AND COSTLY) EFFECTS DUE TO THE INTRODUCTION OF AN UNRESTRICTED REIMBURSEMENT POLICY FOR ATYPICAL ANTIPSYCHOTIC MEDICATIONS IN A CANADIAN PUBLIC PRESCRIPTION DRUG PROGRAM: 1996/97 TO 2005/06

Daria J O’Reilly, Ron A Goeree, Jean-Eric Tarride, Colleen Janes, Patrick S Parfrey
Abstract 158 | PDF Downloads 87
PDF

VIDENCE AND VALUES: REQUIREMENTS FOR PUBLIC REIMBURSEMENT OF DRUGS FOR RARE DISEASES - A CASE STUDY IN ONCOLOGY

Michael Drummond, Bill Evans, Jacques LeLorier, Pierre Karakiewicz, Douglas Martin, Peter Tugwell, Stuart MacLeod
Abstract 544 | PDF Downloads 221
PDF

Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply

Andreas Laupacis
Abstract 159 | PDF Downloads 89
PDF

A Critical Review of: “Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications”

Ran D. Goldman
Abstract 95 | PDF Downloads 63
PDF

ETHYLGLUCURONIDE AND ETHYLSULFATE IN MECONIUM TO ASSESS GESTATIONAL ETHANOL EXPOSURE: PRELIMINARY RESULTS IN TWO MEDITERRANEAN COHORTS

Simona Pichini, Luca Morini, Emilia Marchei, Ilaria Palmi, Maria Concetta Rotolo, Federica Vagnarelli, Oscar Garcia-Algar, Oriol Val, Piergiorgio Zuccaro
Abstract 239 | PDF Downloads 143
PDF

WERE OUR FOREBEARS AWARE OF PRENATAL ALCOHOL EXPOSURE AND ITS EFFECTS? A REVIEW OF THE HISTORY OF FETAL ALCOHOL SPECTRUM DISORDER

James L Sanders
Abstract 509 | PDF Downloads 410
PDF

THE RELATION BETWEEN THEORY OF MIND AND EXECUTIVE FUNCTIONS IN CHILDREN WITH FETAL ALCOHOL SPECTRUM DISORDERS

Carmen Rasmussen, Katy Wyper, Victoria Talwar
Abstract 1321 | PDF Downloads 535
PDF